Lidocaine for Endometrial Biopsy
Trial Summary
What is the purpose of this trial?
The objective of this study is to to determine whether 1% lidocaine paracervical block reduces pain during endometrial biopsy in comparison to no intervention.The proposed study is a double-blind randomized controlled trial (RCT).Each participant will be randomly assigned to one of two arms:1. intervention (paracervical block - 10 mL 1% lidocaine with epinephrine)2. control (gently tapping the cervicovaginal junction with a capped needle)The primary outcome will be a global pain score, which will be patient-reported by the 100 mm Visual Analogue Scale (VAS) following the procedure.
Eligibility Criteria
This trial is for English-speaking individuals who need an endometrial biopsy. It's open to people of all parities, meaning it doesn't matter if they've had children before or not.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endometrial biopsy with either a paracervical block or a control procedure
Follow-up
Participants are monitored for immediate complications and pain scores are recorded
Treatment Details
Interventions
- 1% Lidocaine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mount Sinai Hospital, Canada
Lead Sponsor